Roy Jakobs

But the FDA has also not said that kind of we have not delivered safe products to the market. They've asked us questions on testing, which we have fulfilled. And as I said, the testing has demonstrated that actually we have been delivering safe and effective products. So for me, there's a difference between patient safety in this case and the learning and the need to improve how we actually run

But the FDA has also not said that kind of we have not delivered safe products to the market. They've asked us questions on testing, which we have fulfilled. And as I said, the testing has demonstrated that actually we have been delivering safe and effective products. So for me, there's a difference between patient safety in this case and the learning and the need to improve how we actually run

But the FDA has also not said that kind of we have not delivered safe products to the market. They've asked us questions on testing, which we have fulfilled. And as I said, the testing has demonstrated that actually we have been delivering safe and effective products. So for me, there's a difference between patient safety in this case and the learning and the need to improve how we actually run

process, how we adhere to that, and how we fully fulfill the needs that was required and that are required by the regulator.

process, how we adhere to that, and how we fully fulfill the needs that was required and that are required by the regulator.

process, how we adhere to that, and how we fully fulfill the needs that was required and that are required by the regulator.

And there we agreed to go into this trajectory where we are fully committed, I'm fully committed, the whole company is fully committed to take patient safety and quality to a different level, including doing it specifically for the case of the sleep and respiratory care business, where this consent decree then was coming into place.

And there we agreed to go into this trajectory where we are fully committed, I'm fully committed, the whole company is fully committed to take patient safety and quality to a different level, including doing it specifically for the case of the sleep and respiratory care business, where this consent decree then was coming into place.

And there we agreed to go into this trajectory where we are fully committed, I'm fully committed, the whole company is fully committed to take patient safety and quality to a different level, including doing it specifically for the case of the sleep and respiratory care business, where this consent decree then was coming into place.

I think you learn through this experience for sure. The learning in terms of progressive insight along the journey is something that is really important, how to deal with that in the best possible way. Because as I said, when we started, for example, the recall versus where we are now is a completely different perspective from also insights.

I think you learn through this experience for sure. The learning in terms of progressive insight along the journey is something that is really important, how to deal with that in the best possible way. Because as I said, when we started, for example, the recall versus where we are now is a completely different perspective from also insights.

I think you learn through this experience for sure. The learning in terms of progressive insight along the journey is something that is really important, how to deal with that in the best possible way. Because as I said, when we started, for example, the recall versus where we are now is a completely different perspective from also insights.

And that means even that actually, if you look at it now, yeah, would you have done things differently? Yes. We might even have done the recall differently. We might have established the process differently in terms of making sure that we could replace them in the best possible way, in the fastest possible way.

And that means even that actually, if you look at it now, yeah, would you have done things differently? Yes. We might even have done the recall differently. We might have established the process differently in terms of making sure that we could replace them in the best possible way, in the fastest possible way.

And that means even that actually, if you look at it now, yeah, would you have done things differently? Yes. We might even have done the recall differently. We might have established the process differently in terms of making sure that we could replace them in the best possible way, in the fastest possible way.

We went all out to kind of ramp up and I was in a very challenging period, but they're still learning in terms of how can you do that better with more supply? Take an example. Can you have a flexible supply chain where you have multiple suppliers instead of single source?

We went all out to kind of ramp up and I was in a very challenging period, but they're still learning in terms of how can you do that better with more supply? Take an example. Can you have a flexible supply chain where you have multiple suppliers instead of single source?

We went all out to kind of ramp up and I was in a very challenging period, but they're still learning in terms of how can you do that better with more supply? Take an example. Can you have a flexible supply chain where you have multiple suppliers instead of single source?

Single source makes you dependent on fewer suppliers, then it's harder to scale up and therefore it was harder for us to kind of go with the fastest track that was kind of there, although we already kind of quadrupled our production. And so those are things. The other learning in decision making is also kind of

Single source makes you dependent on fewer suppliers, then it's harder to scale up and therefore it was harder for us to kind of go with the fastest track that was kind of there, although we already kind of quadrupled our production. And so those are things. The other learning in decision making is also kind of